IP Verse

Teva Uk competitive analysis

Explore patent oppositions filed by Teva Uk against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026

Patent Number	Title	Applicant	Opposition Date
EP3578169	Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)Phenol	GLAXO GROUP	Mar 26, 2025
EP3335707	Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist	GLAXO GROUP	Jan 17, 2025
EP3650019	Fluticasone Furoate In The Treatment Of Copd	GLAXOSMITHKLINE	Jun 6, 2024
EP3860590	Methods For The Treatment Of Scleroderma	ARENA PHARMACEUTICALS	Feb 29, 2024
EP3461474	Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties And Methods Of Administering The Same	GLAXOSMITHKLINE	Jul 13, 2021
EP2228064	Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor Agonist	NOVARTIS	Sep 8, 2020
EP3148521	Fluticasone Furoate In The Treatment Of Copd	GLAXOSMITHKLINE	Sep 8, 2020
EP3034073	Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of Asthma	CHIESI FARMACEUTICI	Mar 4, 2020
EP2400950	Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)Phenol	GLAXO GROUP	Feb 21, 2020
EP2611422	Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties And Methods Of Administering The Same	GLAXOSMITHKLINE	Jun 14, 2019

Discover the latest PTAB cases involving Teva Uk, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Teva Uk with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
TEVA PHARMACEUTICALS	218	19	17	12
GLAXO GROUP	13	29	-	-
GLAXOSMITHKLINE	29	128	6	3
VECTURA	15	13	-	-